Lexeo Therapeutics (LXEO) Long-Term Investments (2024 - 2026)
Lexeo Therapeutics (LXEO) reported Long-Term Investments of $3.4 million for Q1 2026, down 51.81% on a YoY basis from $7.0 million in Q1 2025, and down 94.77% sequentially from $64.8 million in Q4 2025.
Lexeo Therapeutics (LXEO) Long-Term Investments (2024 - 2026) Analysis & Trends
Lexeo Therapeutics (LXEO) has 3 years of Long-Term Investments data on file, last reported at $3.4 million in Q1 2026.
- For the quarter ending Q1 2026, Long-Term Investments fell 51.81% year-over-year to $3.4 million; the trailing twelve-month figure through Mar 2026 stood at $3.4 million (down 51.81% YoY), and the FY2025 full-year result was $64.8 million, up 824.14% from the prior year.
- Long-Term Investments declined to $3.4 million in Q1 2026, from $64.8 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $64.8 million in Q4 2025 to a low of $3.4 million in Q2 2025.
- A 3-year average of $14.8 million and a median of $5.2 million in 2024 frame the typical range for Long-Term Investments.
- Across the five-year window, Long-Term Investments surged 824.14% in 2025 and slumped 51.81% in 2026, its largest moves.
- Tracing LXEO's Long-Term Investments over 3 years: stood at $7.0 million in 2024, then surged by 824.14% to $64.8 million in 2025, then slumped by 94.77% to $3.4 million in 2026.
- Business Quant data shows LXEO's Long-Term Investments at $3.4 million in Q1 2026, $64.8 million in Q4 2025, and $3.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 505,194.89 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Lexeo Therapeutics | 382.38 Mn | 382.38 Mn | - | 3.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.39 Mn |
| Dec 31, 2025 | 64.80 Mn |
| Sep 30, 2025 | 3.39 Mn |
| Jun 30, 2025 | 3.39 Mn |
| Mar 31, 2025 | 7.04 Mn |
| Dec 31, 2024 | 7.01 Mn |